Article ID Journal Published Year Pages File Type
5705630 Ophthalmology 2016 7 Pages PDF
Abstract
Introduction of anti-VEGF agents in 2006 for treating exudative AMD has not posed a threat of increased risk of AMI, stroke, or all-cause mortality.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , ,